| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |